Wells Fargo Maintains Overweight on Globus Medical, Lowers Price Target to $99

Benzinga Newsdesk www.benzinga.com Negative 70.3%

Neg 70.3% Neu 0% Pos 0%

Wells Fargo analyst Larry Biegelsen maintains Globus Medical (NYSE:GMED) with a Overweight and lowers the price target from $103 to $99.